Background: Modern medicine faces distinct challenges in managing acute hyperinflammatory syndromes and chronic developmental sequelae. This article synthesizes evidence regarding Hemophagocytic Lymphohistiocytosis (HLH), a life-threatening immune dysregulation, and the long-term neurocognitive outcomes of preterm birth, representing two critical ends of the patient vulnerability spectrum.
Methods: We reviewed recent literature regarding HLH diagnostic criteria, specifically focusing on bone marrow histomorphology and the HScore, alongside meta-analyses of executive function (EF) in children born preterm. Efficacy data on etoposide regimens and global preterm birth statistics were analyzed to provide a holistic view of patient outcomes.
Results: Diagnostic precision in HLH remains difficult; bone marrow hemophagocytosis is sensitive but lacks specificity without the HScore. Malignancy-associated HLH, particularly T-cell lymphoma, carries the highest mortality. In the pediatric domain, survivors of preterm birth exhibit persistent deficits in executive functions—specifically working memory and inhibition—which significantly hinder academic performance at school age.
Conclusions: Effective management of vulnerable populations requires a dual focus: rapid, accurate diagnosis for acute crises like HLH using improved indices, and sustained neurodevelopmental support for preterm survivors. The intersection of inflammatory susceptibility and developmental fragility warrants further investigation to optimize long-term quality of life.
Publication Date: 2026-06-08